ICON Public (ICLR) Expected to Announce Quarterly Earnings on Wednesday

ICON Public (NASDAQ:ICLR) will likely be announcing its earnings results after the market closes on Wednesday, February 19th. Analysts expect the company to announce earnings of $3.41 per share and revenue of $2.04 billion for the quarter. Investors interested in registering for the company’s conference call can do so using this link.

ICON Public Stock Down 1.8 %

Shares of ICLR stock opened at $187.35 on Wednesday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.34 and a current ratio of 1.34. The firm’s 50-day moving average is $206.56 and its 200-day moving average is $251.78. The stock has a market cap of $15.46 billion, a price-to-earnings ratio of 20.89, a PEG ratio of 1.78 and a beta of 1.19. ICON Public has a 52-week low of $183.38 and a 52-week high of $347.72.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on ICLR shares. Truist Financial reaffirmed a “buy” rating and issued a $284.00 target price (down from $295.00) on shares of ICON Public in a report on Wednesday, December 18th. Citigroup dropped their target price on shares of ICON Public from $300.00 to $290.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Barclays decreased their price target on shares of ICON Public from $330.00 to $275.00 and set an “overweight” rating on the stock in a research note on Friday, October 25th. JPMorgan Chase & Co. decreased their price target on shares of ICON Public from $280.00 to $265.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. Finally, William Blair reiterated an “outperform” rating on shares of ICON Public in a research note on Tuesday, January 14th. Four analysts have rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $285.75.

About ICON Public

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.